IS:SYNGENE Syngene International Limited

Syngene International Limited, a contract research and manufacturing company, provides integrated drug discovery and development services in India and internationally. The company offers discovery chemistry services, including medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, and computational and discovery analytical chemistry; and discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals. It also provides development services in biologics; and carries out exploratory/discovery, battery of genetic, and developmental and reproductive, as well as acute, sub-chronic, and chronic toxicity studies. In addition, the company offers chemical development, formulation development, and polymer research services; and analytical services for small and large molecules. Further, it provides target identification and validation, lead generation and optimization, lead selection, preclinical development, API, and drug product development services for small and large molecules. Additionally, the company offers clinical trial management, PK analysis/bioanalytical, central lab, laboratory, biometrics and clinical data management, regulatory, medical monitoring, pharmacovigilance, and medical writing services. It also provides bioinformatics research, antibody drug conjugate discovery and development, and oligonucleotide synthesis services. The company serves pharmaceutical/biotech, agrochemical, nutrition, animal health, specialty and performance chemicals, and other industries. It has partnerships with Bristol-Myers Squibb Co.; Baxter International Inc.; Amgen Inc.; GSK; and Herbalife Nutrition. The company was incorporated in 1993 and is based in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.

597.40 INR
As of 01/21/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  India
Country of incorporation:  India
IPO date:  08/18/2015
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   243,848,118,272 INR
Current dividend yield:   0.08%
Sedol:      BYXXQB6

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy